Evidence map›Paper›PMID 40266384›Full record

ArticleSleep & breathing = Schlaf & Atmung2025

Clinical characteristics and medication use patterns of middle-aged and older adults with sleep apnea with and without comorbid insomnia.

Chien-Yu Tseng, Earl J Morris, Vishaldeep K Sekhon, Jennifer S Albrecht, Emerson M Wickwire, Adam P Spira, Alden L Gross, Atul Malhotra, Marcela D Blinka, Christopher N Kaufmann

Abstract read
In one paragraph

Article in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chien-Yu TsengDepartment of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA. chienyutseng@ufl.edu.ORCID 0000-0001-7490-0077
Earl J MorrisDepartment of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA.ORCID 0000-0002-6092-8906
Vishaldeep K SekhonCenter on Aging and Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0009-0009-5040-4402
Jennifer S AlbrechtDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-4838-2274
Emerson M WickwireDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-2858-7742
Adam P SpiraCenter on Aging and Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-1507-0995
Alden L GrossCenter on Aging and Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-3276-2897
Atul MalhotraDivision of Pulmonary, Critical Care, Sleep Medicine and Physiology, School of Medicine, University of California, San Diego, CA, USA.ORCID 0000-0002-9509-1827
Marcela D BlinkaCenter on Aging and Health, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-0369-9331
Christopher N KaufmannDepartment of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA. ckaufmann@ufl.edu.ORCID 0000-0002-2946-7857

Funding

Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARILYN S. ALBERT · 2020 to 2026
$29.3M
University of Florida Older Americans Independence Center (OAIC)P30AG028740 · NIA · UNIVERSITY OF FLORIDA · PI Karyn A Esser, Todd Manini · 2007 to 2026
$22.8M
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's DiseaseR01AG063925 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, ATUL · 2020 to 2024
$3.7M
Underlying mechanisms of obesity-induced obstructive sleep apneaR01HL148436 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Atul Malhotra · 2020 to 2026
$3.4M
Sleep Apnea Endophenotypes: One Size Does Not Fit AllR01HL154926 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, ATUL · 2021 to 2025
$3.3M
Sleep apnea treatment and risk for cognitive decline and Alzheimers diseaseR01AG079391 · NIA · UNIVERSITY OF FLORIDA · PI Christopher Norfleet Kaufmann · 2022 to 2026
$3.1M
The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)R01HL166485 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Atul Malhotra · 2023 to 2026
$3.1M
VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19R01HL157985 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MALHOTRA, ATUL, NEMATI, SHAMIM · 2022 to 2025
$2.9M
Developing a Diverse Next Generation of Leaders in Respiratory ScienceT32HL166127 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Laura Elise Crotty Alexander, Atul Malhotra · 2023 to 2026
$1.6M
Sedative-Hypnotic Use Patterns and Risk for Cognitive Decline and Alzheimer's DiseaseK01AG061239 · NIA · UNIVERSITY OF FLORIDA · PI KAUFMANN, CHRISTOPHER NORFLEET · 2019 to 2023
$656k
NHLBI NIH HHS R01 HL148436NHLBI NIH HHS R01 HL154926NHLBI NIH HHS R01 HL157985NHLBI NIH HHS R01 HL166485NHLBI NIH HHS T32 HL166127NIA NIH HHS K01 AG061239NIA NIH HHS K01AG061239NIA NIH HHS P30 AG028740NIA NIH HHS P30AG028740NIA NIH HHS P30 AG066507NIA NIH HHS R01 AG063925NIA NIH HHS R01 AG079391NIA NIH HHS R01AG079391Sleep Research Society Foundation 23-FRA-001
6 · The paper itself

Abstract

purposeComorbid insomnia and sleep apnea (COMISA) is a prevalent clinical syndrome. We characterized differences in characteristics and medication use patterns between participants with COMISA and those with sleep apnea alone.

methodsData used came from 2018 Health and Retirement Study, a nationally representative cohort study of U.S. middle-aged and older adults. Participants were asked if "a doctor had ever told them they have a sleep disorder" and which disorder. They also reported frequency of insomnia symptoms (i.e., "falling asleep," "waking during the night," "waking too early,") and how often they "felt rested in the morning." We tested differences in demographic and clinical characteristics as well as medication use between participants with COMISA vs. those with sleep apnea alone by using logistic regression.

resultsOut of N = 1,776 with sleep apnea, 47% had COMISA. Compared to those with sleep apnea alone, participants with COMISA were more likely to be female (p = 0.032), have lower education (p < 0.001), and report lung disease, stroke, psychiatric problems, and dementia/cognitive impairment (all p's < 0.001). They reported difficulty in functioning (i.e., activities of daily living), and greater depressive symptomatology (all p's < 0.001). Finally, they were more likely to report the use of opioids (p = 0.037), stomach (p = 0.028), and sleep medications (p < 0.001).

conclusionsCompared to those with sleep apnea alone, COMISA participants had a more medically complex health profile and medication use that may exacerbate sleep apnea (e.g., opioids and sleep medications). Future research should focus on managing COMISA in medically complex patients for improved health outcomes.

Indexed as

Sleep Apnea SyndromesSleep Initiation and Maintenance DisordersAgedAged, 80 and overCohort StudiesComorbidityFemaleHumansMaleMiddle AgedUnited StatesCOMISAHealth and Retirement StudyMedication patternsOlder adultsSleep apnea

Identifiers

PMID40266384
PMCPMC12227114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.